Ditran

Ditran is a psychoactive drug that belongs to the hallucinogen category. It is a mixture of two active compounds, JB-329 and JB-336, which are both belladonna alkaloids. Ditran is known for its psychotomimetic effects, which can mimic the symptoms of psychosis, including hallucinations, delusions, and disorganized speech.

History[edit | edit source]

Ditran was first synthesized in the 1960s by the pharmaceutical company Janssen Pharmaceutica. It was initially used in psychiatric research to induce a state of psychosis in healthy individuals, in order to better understand the nature of psychotic disorders such as schizophrenia and bipolar disorder.

Pharmacology[edit | edit source]

Ditran acts as an antagonist at the muscarinic acetylcholine receptor, which is involved in various physiological functions such as heart rate, digestion, and salivation. By blocking the action of acetylcholine, Ditran can induce a state of delirium characterized by confusion, disorientation, and hallucinations.

Effects[edit | edit source]

The effects of Ditran can vary greatly depending on the dose and individual's sensitivity to the drug. At lower doses, Ditran can cause mild euphoria, visual distortions, and altered perception of time. At higher doses, it can induce a state of psychosis, with symptoms such as hallucinations, delusions, and disorganized speech.

Risks and Safety[edit | edit source]

Ditran is a powerful hallucinogen and can have serious side effects, including tachycardia, hyperthermia, and seizures. It can also cause severe psychological effects, such as anxiety, paranoia, and psychotic episodes. Due to these risks, Ditran is not commonly used recreationally and is considered a controlled substance in many countries.